Task Force on Synthetic Biology and the Bioeconomy releases landmark U.S. Bioeconomy Report
The Task Force on Synthetic Biology and the Bioeconomy has released its report — THE U.S. BIOECONOMY: CHARTING A COURSE FOR A RESILIENT AND COMPETITIVE FUTURE”.
The report contains recommendations and a strategy to help realize the potential of the U.S. bioeconomy for maximum public benefit. A key focus of the task force is to bring multiple types of capital to bear to accelerate and expand biotechnology applications, including carbon management and sustainability. Members of the task force include subject matter experts across academic disciplines, including physics, ethics, and synthetic biology; venture capitalists and industry leaders from both small and large companies; and leaders from the biotechnology consortia.
In the summer of 2021, the Congressional Research Service released its report, Bioeconomy: A Primer, which describes options for Congress to advance the U.S. bioeconomy. In October, the Biden Administration released a National Advanced Manufacturing Strategy Request for Information that included cutting-edge nano, chemical, and biological technologies. These actions demonstrate growing momentum and opportunity to maximize the potential of the bioeconomy for public benefit.
To seed the next wave of innovation in synthetic biology and the bioeconomy, Schmidt Futures launched the task force in October 2021. The program aims to advance transformative bio-based and bio-enabled applications in areas such as health, clean energy, industry, and agriculture.
